Want to join the conversation?
Michael Nannizzi of Goldman Sachs asks about $WLTW's legacy Willis organic growth. CEO John Haley said the company is confident in improved organic growth going through the year and although a bit muted, $WLTW is moderately well-positioned for this growth.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.